Stocktoria
INSULET CORP PODD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-05-15
INSULET CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 71.6% | 69.8% | 68.3% | 61.7% | 68.4% |
| Operating margin | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% |
| Net margin | 9.1% | 20.2% | 12.2% | 0.4% | 1.5% |
| FCF margin | 13.9% | 14.7% | 4.1% | -0.3% | -16.4% |
| Return on assets | 7.7% | 13.5% | 8.0% | 0.2% | 0.8% |
| Return on equity | 16.3% | 34.5% | 28.2% | 1.0% | 3.0% |
| Debt / equity | — | — | — | 2.94× | 2.29× |
| Current ratio | 2.81 | 3.58 | 3.51 | 3.60 | 5.81 |
| Revenue growth | 30.7% | 22.1% | 30.0% | 18.8% | 21.5% |
Source: SEC EDGAR filings · CIK 0001145197 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.